AR009626A1 - Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa. - Google Patents

Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa.

Info

Publication number
AR009626A1
AR009626A1 ARP970105454A ARP970105454A AR009626A1 AR 009626 A1 AR009626 A1 AR 009626A1 AR P970105454 A ARP970105454 A AR P970105454A AR P970105454 A ARP970105454 A AR P970105454A AR 009626 A1 AR009626 A1 AR 009626A1
Authority
AR
Argentina
Prior art keywords
dermatological
sphingomyelinase
skin
produce
ceramides
Prior art date
Application number
ARP970105454A
Other languages
English (en)
Original Assignee
Cavaliere Renata Maria Anna
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cavaliere Renata Maria Anna, Simone Claudio De filed Critical Cavaliere Renata Maria Anna
Publication of AR009626A1 publication Critical patent/AR009626A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/04—Phosphoric diester hydrolases (3.1.4)
    • C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/854—Lactobacillus acidophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/855—Lactobacillus brevis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/856—Lactobacillus casei
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus
    • Y10S435/857—Lactobacillus plantarum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Uso de esfingomielinasa para producir composiciones dermatologicas y/o cosméticas, adecuadas para ser topicamente aplicadas, a los efectos de aumentarlos niveles de ceramidas de la piel y de las mucosas y composiciones dermatologicasy cosméticas que contienen la misma.
ARP970105454A 1996-11-22 1997-11-21 Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa. AR009626A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000799A IT1296148B1 (it) 1996-11-22 1996-11-22 Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte

Publications (1)

Publication Number Publication Date
AR009626A1 true AR009626A1 (es) 2000-04-26

Family

ID=11404547

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105454A AR009626A1 (es) 1996-11-22 1997-11-21 Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa.

Country Status (20)

Country Link
US (4) US6258355B1 (es)
EP (1) EP0941056B1 (es)
JP (2) JP4965008B2 (es)
KR (1) KR100508407B1 (es)
CN (2) CN1840183A (es)
AR (1) AR009626A1 (es)
AT (1) ATE218850T1 (es)
AU (1) AU732203B2 (es)
BR (1) BR9713287A (es)
CA (1) CA2271762C (es)
DE (1) DE69713379T2 (es)
DK (1) DK0941056T3 (es)
EA (1) EA001741B1 (es)
ES (1) ES2176795T3 (es)
HK (1) HK1024636A1 (es)
IL (1) IL130037A (es)
IT (1) IT1296148B1 (es)
MX (1) MX216017B (es)
PT (1) PT941056E (es)
WO (1) WO1998022082A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
RO113114B1 (ro) * 1997-08-05 1998-04-30 Rodica Teodorescu Produs eubiotic natural, pentru intretinerea si tratamentul tegumentelor
KR100577914B1 (ko) * 1998-10-09 2006-05-10 가부시키가이샤 야쿠루트 혼샤 피부 외용제
IT1311495B1 (it) * 1999-06-09 2002-03-13 Mendes S U R L Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
US8697051B2 (en) 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
DE10037046A1 (de) * 2000-07-29 2002-02-21 Jean Krutmann Verwendung von N-Oleoylethanolamin zur Behandlung der Schuppenflechte (Psoriasis)
EP1287815A1 (en) * 2001-08-31 2003-03-05 Cosmoferm B.V. Use of a sphingoid base for inhibiting ceramidase activity
US6869519B2 (en) * 2001-09-27 2005-03-22 National Institute Of Advanced Industrial Science And Technology Electrolytic process for the production of metallic copper and apparatus therefor
US7585518B2 (en) * 2002-11-19 2009-09-08 Kimberly-Clark Worldwide, Inc. Products and methods for maintaining or increasing ceramide levels in skin
US7037535B2 (en) * 2002-11-19 2006-05-02 Kimberly-Clark Worldwide, Inc. Method and composition for neutralizing house dust mite feces
US20050019379A1 (en) 2003-07-22 2005-01-27 Kimberly-Clark Worldwide, Inc. Wipe and methods for improving skin health
EP2514427A1 (en) * 2004-03-04 2012-10-24 E-L Management Corp. Skin treatment method with lactobacillus extract
US7374750B2 (en) * 2004-05-14 2008-05-20 Jennifer Albano Probiotic containing anhydrous hair care composition
KR20070070153A (ko) * 2004-06-23 2007-07-03 로레알 민감성 및/또는 건성 피부의 예방 및/또는 치료에 유용한방법 및 조성물
ITMI20041550A1 (it) * 2004-07-29 2004-10-29 Proge Farm Srl Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
US20060045894A1 (en) * 2004-09-01 2006-03-02 Vera Brown Compound for neck skin firming
US20080124306A1 (en) * 2006-11-28 2008-05-29 Kiminobu Sugaya Vigor Enhancement Via Administration of Pyrimidine Derivatives
WO2008064893A1 (en) * 2006-12-01 2008-06-05 Organobalance Gmbh Compositions, kits and uses for protecting the skin against pathogenic microorganisms
JP2010047504A (ja) * 2008-08-20 2010-03-04 Nippon Meat Packers Inc アトピー性皮膚炎緩和剤
FR2937536B1 (fr) * 2008-10-28 2016-07-01 Oreal Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
CN102648003B (zh) * 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
CA2801689A1 (en) * 2010-06-08 2011-12-15 Calpis Co., Ltd. Broken cells of lactic acid bacteria for improving lipid metabolism
CN102626424A (zh) * 2012-04-28 2012-08-08 王飞 一种活性抑菌胶囊
CN104232537B (zh) * 2014-09-03 2017-04-12 中国科学院微生物研究所 一株弯曲乳杆菌及其应用
TW201630596A (zh) * 2015-01-06 2016-09-01 Meiji Co Ltd 鞘脂質吸收促進劑
EP3362038A4 (en) * 2015-10-15 2019-05-15 Natura Cosméticos S.A. COSMETIC COMPOSITION CONTAINING PROBIOTIC BACTERIA
US10238597B2 (en) * 2015-11-19 2019-03-26 Beauty Biolabs Llc Probiotic treatment of skin diseases, disorders, and infections: formulations, methods and systems
KR101917497B1 (ko) 2017-02-18 2018-11-09 박병희 신규한 락토바실러스 부크네리 및 이의 용도
KR101912380B1 (ko) * 2017-03-15 2018-10-26 (주)바이오일레븐 프로바이오틱스의 방출 및 프로바이오틱스 효소 활성의 유지를 위한 점막점착성 장치
KR102311725B1 (ko) * 2017-09-27 2021-10-13 (주)아모레퍼시픽 락토바실러스 크러스토룸의 배양물 또는 이의 추출물을 포함하는 조성물
RU2681545C1 (ru) * 2017-11-27 2019-03-11 Федеральное государственное бюджетное учреждение науки "Институт морских биологических исследований имени А.О. Ковалевского РАН" Способ получения крем-маски (варианты)
IT201800002052A1 (it) * 2018-01-26 2019-07-26 Girolamo Stefano Di Probiotico per il trattamento della psoriasi
CN110151672B (zh) * 2018-02-12 2022-04-05 景岳生物科技股份有限公司 一种植物乳杆菌gmnl-6组合物用于皮肤保养的用途
FR3117340B1 (fr) * 2020-12-15 2024-01-05 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant
FR3134010A1 (fr) 2022-03-30 2023-10-06 Basf Beauty Care Solutions France Sas Utilisation cosmétique, nutraceutique et/ou dermatologique d’une souche de Lactobacillus crispatus et/ou d’une composition la comprenant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085228A (en) * 1976-08-18 1978-04-18 Leprino Cheese Co. Preparation of pizza cheese
PL193146A1 (pl) * 1976-10-19 1978-04-24 Inst Przemyslu Mleczarskiego Preparat enzymatyczny do dojrzewania bialkowych produktow mleczarskich
GB2037160B (en) * 1978-12-08 1983-02-09 Dso Pharmachim Milk derived products
KR800001462B1 (ko) * 1979-05-01 1980-12-10 강원명 탈지유로부터 화장품 원료를 제조하는 방법
JPS63216813A (ja) * 1987-03-05 1988-09-09 Noebia:Kk 皮膚用組成物
JP3112983B2 (ja) * 1991-05-31 2000-11-27 御木本製薬株式会社 化粧料
KR950014592B1 (ko) * 1991-10-22 1995-12-11 주식회사태평양 화장료용 유산균제재
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP3413220B2 (ja) * 1992-08-17 2003-06-03 株式会社コーセー 肌荒れ改善剤
FR2729079A1 (fr) 1995-01-09 1996-07-12 Sederma Sa Nouvelles compositions cosmetiques contenant des ceramides et autres lipides complexes
JP3122333B2 (ja) * 1995-02-28 2001-01-09 株式会社薬理学中央研究所 赤血球を原料とするスフィンゴミエリンおよびセラミドの新規製造方法とセラミド配合治療剤又は化粧品
US5830916A (en) * 1996-05-23 1998-11-03 Duke University Inhibitor of ceramidase
IT1296148B1 (it) * 1996-11-22 1999-06-09 Renata Maria Anna Ve Cavaliere Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche

Also Published As

Publication number Publication date
US6582695B2 (en) 2003-06-24
MX9904749A (es) 2000-04-30
ITRM960799A1 (it) 1998-05-22
ITRM960799A0 (it) 1996-11-22
WO1998022082A1 (en) 1998-05-28
JP2001505201A (ja) 2001-04-17
HK1024636A1 (en) 2000-10-20
BR9713287A (pt) 1999-10-26
CA2271762A1 (en) 1998-05-28
CN1840183A (zh) 2006-10-04
ATE218850T1 (de) 2002-06-15
ES2176795T3 (es) 2002-12-01
US6258355B1 (en) 2001-07-10
DE69713379D1 (de) 2002-07-18
IT1296148B1 (it) 1999-06-09
KR100508407B1 (ko) 2005-08-17
AU732203B2 (en) 2001-04-12
CN1243536C (zh) 2006-03-01
US6962697B2 (en) 2005-11-08
PT941056E (pt) 2002-11-29
KR20000057210A (ko) 2000-09-15
DK0941056T3 (da) 2002-07-15
EA199900486A1 (ru) 1999-12-29
CN1240345A (zh) 2000-01-05
IL130037A0 (en) 2000-02-29
EP0941056A1 (en) 1999-09-15
CA2271762C (en) 2011-03-15
US20030086917A1 (en) 2003-05-08
US20030077269A1 (en) 2003-04-24
IL130037A (en) 2004-06-01
DE69713379T2 (de) 2003-02-13
JP4965008B2 (ja) 2012-07-04
EA001741B1 (ru) 2001-08-27
AU5134098A (en) 1998-06-10
MX216017B (es) 2003-08-26
JP2009138006A (ja) 2009-06-25
EP0941056B1 (en) 2002-06-12
US20050265986A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
AR009626A1 (es) Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa.
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
AR004468A1 (es) Composicion cosmetica o dermatologica del tipo agua en aceite
ES2176700T3 (es) Composiciones para la piel.
AR005234A1 (es) Un tratamiento para la piel estructuralmente deteriorada y composicion cosmetica utilizada en el mismo
ES2154503T3 (es) Composicion cosmetica o dermatologica.
PT100962A (pt) Composicoes cosmeticas do tipo gel que compreendem uma poliacrilamida nao-ionica
CO4130178A1 (es) Composicion para el cuidado personal en forma de gel, que tiene propiedades viscoelasticas
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
ES2090631T3 (es) Utilizacion de esfingolipidos, en la preparacion de una composicion cosmetica o dermofarmaceutica que protege la piel y los cabellos contra los efectos nocivos de la polucion atmosferica.
AU6408298A (en) Essential oil composition
PT841898E (pt) COMPOSICOES TóPICAS QUE PROPORCIONAM UMA MELHOR SENSACAO DA PELE
ES2185241T3 (es) Utilizacion de composiciones cosmeticas que contienen al menos una uxina.
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
ES2102275T3 (es) Composicion cosmetica o dermatologica que contiene una mezcla de ceramidas, su utilizacion para hidratar la piel.
BR9403783A (pt) Uso de uma composição cosmética
ES2129274T3 (es) Composicion cosmetica para aplicar sobre un soporte queratinico que comprende al menos dos polimeros y utilizacion.
AR026490A1 (es) Composiciones cosmeticas que contienen extracto de garbanzo en combinacion con retinoides y metodo cosmetico de aplicacion de dicha composicion
CO5160321A1 (es) Novedosas composiciones de tipranavir y ritonavir
MXPA01011941A (es) Humectante cosmetico no pegajoso para la piel y el cabello.
AR017222A1 (es) Procedimiento de utilizacion de un agente que inhibe el desarrollo de p.ovale, en la preparacion de medicamentos
ES2137044T3 (es) Utilizacion de derivados de oxazolidinona como agentes antipenetrantes en una composicion cosmetica y/o dermatologica.
BR0307494A (pt) Composição que contêm extrato de palha de aveia e de erva de salgueiro
BR0203109A (pt) Composição de cuidado com a pele que altera a cor sob secagem

Legal Events

Date Code Title Description
FG Grant, registration